Verano Holdings (VRNO) Operating Expenses (2021 - 2026)
Verano Holdings' (VRNO) quarterly Operating Expenses came in at $85.9 million in Q1 2026, up 1.53% year-on-year from $84.6 million in Q1 2025, and down 67.38% on a QoQ basis from $263.3 million in Q4 2025.
Verano Holdings (VRNO) Operating Expenses (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Operating Expenses data on file, last reported at $85.9 million in Q1 2026.
- On a quarterly basis, Operating Expenses rose 1.53% year-over-year to $85.9 million in Q1 2026; TTM through Mar 2026 was $521.9 million, a 22.73% decrease from a year earlier, with the FY2025 full-year figure at $520.6 million, down 23.57% from the prior year.
- Operating Expenses for Q1 2026 stood at $85.9 million, down from $263.3 million in the prior quarter.
- Over the last five years, Operating Expenses for VRNO reached as high as $411.4 million in Q4 2024 and fell as low as $9.6 million in Q1 2022.
- Historically, Operating Expenses has averaged $128.4 million across 5 years, with a median of $87.1 million in 2024.
- On a YoY basis, Operating Expenses climbed as much as 686.07% in 2023 and fell as far as 55.73% in 2023.
- Year by year, Operating Expenses stood at $310.2 million in 2022, then plunged by 55.73% to $137.3 million in 2023, then jumped by 199.6% to $411.4 million in 2024, then sank by 36.01% to $263.3 million in 2025, then sank by 67.38% to $85.9 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $85.9 million in Q1 2026, $263.3 million in Q4 2025, and $86.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 85.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.88 Mn |
| Dec 31, 2025 | 263.28 Mn |
| Sep 30, 2025 | 85.96 Mn |
| Jun 30, 2025 | 86.77 Mn |
| Mar 31, 2025 | 84.58 Mn |
| Dec 31, 2024 | 411.42 Mn |
| Sep 30, 2024 | 92.33 Mn |
| Jun 30, 2024 | 87.07 Mn |
| Mar 31, 2024 | 90.29 Mn |
| Dec 31, 2023 | 137.32 Mn |
| Sep 30, 2023 | 92.89 Mn |
| Jun 30, 2023 | 84.66 Mn |
| Mar 31, 2023 | 75.24 Mn |
| Dec 31, 2022 | 310.22 Mn |
| Sep 30, 2022 | 85.71 Mn |
| Jun 30, 2022 | 100.26 Mn |
| Mar 31, 2022 | 9.57 Mn |
| Dec 31, 2021 | 81.77 Mn |
| Sep 30, 2021 | 76.48 Mn |
| Jun 30, 2021 | 70.01 Mn |